Free Submission Public Relations & NewsPR-inside.com
Home
Deutsch English

Business

Apira Science Introduces Revolutionary, Hands-Free, In-Home Hair Growth System to Canada iGrow(R) Uses Low-Level Laser Therapy (LLLT) to Grow Hair for People Afflicted With Androgenetic Alopecia, and Other Related Hair Loss Conditions


Print article Print article
© Marketwire 2013

The iGrow is a safe and effective hands-free, in-home Low-Level Laser Therapy system that grows hair thicker and fuller for people afflicted with Androgenetic Alopecia and other related causes of hair thinning and loss.
The iGrow is a safe and effective hands-free, in-home Low-Level Laser Therapy system that grows hair thicker and fuller for people afflicted with Androgenetic Alopecia and other related causes of hair thinning and loss.
2013-02-12 19:53:04 -

BOCA RATON, FL -- (Marketwire) -- 02/12/13 -- Apira Science, Inc. ( www.igrowlaser.ca : ctt.marketwire.com/?release=984440&id=2600086&type=1& .. ) today announced that it has been awarded a Class 2 Medical Device License from the Therapeutic Products Directorate, Medical Devices Bureau of Health Canada, and will immediately commence sales and distribution of its hands-free iGrow® Hair Rejuvenation System to the Canadian market.



Clinically-proven and safe, the iGrow is a revolutionary, in-home, hands-free hair growth system that provides full scalp coverage. It is fully portable, easy to use, and requires no manual movement. The iGrow incorporates a patented, highly effective Low-Level Laser Therapy (LLLT) system that delivers significant hair growth for individuals suffering from Androgenetic Alopecia and other related hair loss conditions.





"As a global leader in aesthetic light-based therapies, further expansion into international markets continues to be a high-level strategic initiative for us, and we are extremely pleased to have been granted a Class 2 Medical Device License from Health Canada," said Nicholas Brox, president and CEO, Apira Science, Inc. "The granting of this license opens the Canadian market for sales and distribution, and represents a significant opportunity for us to address and remedy hair thinning and loss for millions of people who will now have access to our innovative iGrow hair rejuvenation system."



LLLT ( www.igrowlaser.ca/lllt : ctt.marketwire.com/?release=984440&id=2600089&type=1& .. ) is a highly effective hair growth treatment process. iGrow's LLLT-driven system increases cellular activity within the hair follicle, which promotes the proliferation of thicker, fuller and healthier hair.



"Our scientifically-innovative and clinically-proven iGrow Hair Rejuvenation System dispenses a non-invasive, highly efficient combination of laser and LED low-level light to effectively re-energize unhealthy follicle cells, stimulating and stabilizing the production of thicker, fuller, and healthier hair," said Jeff Braile, president, medical products division, Apira Science, Inc. "The extraordinary results from our recently completed double-blind placebo controlled clinical trial cements the fact that individuals who are afflicted with thinning hair and other hair loss conditions can grow hair through consistent use of the iGrow over a period of four to six months."



Apira Science has leveraged decades of scientific research, knowledge and expertise in low-level light therapy to develop and manufacture its in-home, hands-free iGrow Hair Rejuvenation System. The iGrow utilizes similar low-level light technology as professional laser hair growth devices used in hair rejuvenation clinics, and by hair restoration physicians.



iGrow Product Features:
Grows Hair
iGrow's® proprietary Low-Level Laser Therapy (LLLT) technology utilizes a highly effective combination of red laser and LED light diodes to effectively stimulate and energize cellular activity causing an uptake in the natural function of the hair follicle. This proven 4 to 6 month process reverses hair thinning/loss, and effectively grows new healthy hair that is thicker, fuller and more vibrant.



Safe and Effective
The iGrow® is a clinically-proven and safe in-home device, designed and produced specifically for the purpose of growing hair in individuals afflicted with Androgenetic Alopecia (genetic-based hair loss). iGrow's non-invasive, proprietary Low-Level Laser Therapy (LLLT) technology has no side-effects, unlike pharmaceuticals, topicals and pills used to treat hair-loss.



Science and Technology
The revolutionary iGrow® features an optimum blend of proven science and technological achievement, borne from decades of research and development. The iGrow uses the identical low-level laser technology used by professional hair loss medical experts and by hair restoration physicians to effectively grow hair.



Fully Adjustable
The iGrow® features 4 adjustable fit columns with rotating weight distribution for optimum comfort during treatment. Headphones extend and retract to custom fit any head size.



Affordable
iGrow® is not only highly effective, it's affordable as well. A one-time purchase will provide everything you need to grow and maintain strong, healthy hair for a lifetime.



The iGrow is currently available online at: www.igrowlaser.ca : ctt.marketwire.com/?release=984440&id=2600092&type=1& ..



About Apira Science, Inc.
Apira Science, Inc. is an established leader and has been a pioneer in Low Level Light Therapy (LLLT) for over a decade. The iGrow hair growth platform is the result of Apira Science, Inc.'s experience, scientific innovation and knowledge of the application of LLLT. This patented hands-free, home use system is easy to use and provides an effective hair growth treatment for individuals afflicted with androgenetic alopecia.



iGrow is a registered trademark of Apira Science, Inc.



Image Available: www2.marketwire.com/mw/frame_mw?attachid=2225883 : www2.marketwire.com/mw/frame_mw?attachid=2225883




Press contact:
Jeff Braile
President, Medical Products Division
(800) 651-4202
Outside the US: +1 (561) 252-1229
Email Contact : www2.marketwire.com/mw/emailprcntct?id=83197A0A4E0D4A36



Press Information:




Contact Person:


Disclaimer: (c) 2014 Market Wire. All of the press releases contained herein are protected by copyright and other applicable laws, treaties and conventions. Information contained in the releases is furnished by Market Wire's, who warrant that they are solely responsible for the content, accuracy and originality of the information contained therein. All reproduction, other than for an individual user's personal reference, is prohibited without prior written permission.
Latest News
Read the Latest News
www.newsenvoy.com

 


Terms & Conditions | Privacy | About us | Contact PR-inside.com | BidVertiser